Scientific Reports · 2022 · 23 citations · 40 references
EngineeringBioengineeringImmunologyBiosensorsImmunotechnologyInflammationImmunomagnetic SeparationInflammatory BiomarkersMicrofluidic BiosensorsMicrofluidic DevicesMicrofluidic SystemsMicrofluidicsAssayAssay SpecificityFluidizationMicrofluidic Diagnostic PlatformsMicrofluidic PlatformsMicrofluidic SeparationNon-specific Binding ReductionRelapse-free Survival
The cytokine interleukin 6 (IL-6) is involved in the pathogenesis of different inflammatory diseases, including cancer, and its monitoring could help diagnosis, prognosis of relapse-free survival and recurrence. Here, we report an innovative microfluidic approach that uses the fluidization of magnetic beads to specifically extract, preconcentrate and fluorescently detect IL-6 directly on-chip. We assess how the physical properties of the beads can be tuned to improve assay performance by enhancing mass transport, reduce non-specific binding and multiply the detection signal threefold by transitioning between packed and fluidization states. With the integration of a full ELISA protocol in a single microfluidic chamber, we show a twofold reduction in LOD compared to conventional methods along with a large dynamic range (10 pg/mL to 2 ng/mL). We additionally demonstrate its application to IL-6 detection in undiluted serum samples.
40
Cytokine Serum Level During Severe Sepsis in Human IL-6 as a Marker of Severity
PIERRE DAMA, Didier Ledoux, Monique Nys et al. · Annals of Surgery · 1992 · 808 citations · Full text